HK109395A - Pharmaceutical uses of fatty acids - Google Patents

Pharmaceutical uses of fatty acids

Info

Publication number
HK109395A
HK109395A HK109395A HK109395A HK109395A HK 109395 A HK109395 A HK 109395A HK 109395 A HK109395 A HK 109395A HK 109395 A HK109395 A HK 109395A HK 109395 A HK109395 A HK 109395A
Authority
HK
Hong Kong
Prior art keywords
fatty acids
pharmaceutical uses
medicament
currect
dgla
Prior art date
Application number
HK109395A
Other languages
English (en)
Inventor
Horrobin David Frederick
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of HK109395A publication Critical patent/HK109395A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
HK109395A 1989-07-21 1995-07-06 Pharmaceutical uses of fatty acids HK109395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898916734A GB8916734D0 (en) 1989-07-21 1989-07-21 Pharmaceutical and dietary uses of fatty acids

Publications (1)

Publication Number Publication Date
HK109395A true HK109395A (en) 1995-07-14

Family

ID=10660430

Family Applications (1)

Application Number Title Priority Date Filing Date
HK109395A HK109395A (en) 1989-07-21 1995-07-06 Pharmaceutical uses of fatty acids

Country Status (14)

Country Link
EP (1) EP0409559B1 (xx)
JP (1) JPH0366616A (xx)
AT (1) ATE116849T1 (xx)
AU (1) AU625705B2 (xx)
CA (1) CA2021000A1 (xx)
DE (1) DE69015910T2 (xx)
DK (1) DK0409559T3 (xx)
ES (1) ES2066134T3 (xx)
GB (1) GB8916734D0 (xx)
GR (1) GR3015722T3 (xx)
HK (1) HK109395A (xx)
IE (1) IE64910B1 (xx)
NZ (1) NZ234528A (xx)
ZA (1) ZA905437B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125602D0 (en) * 1991-12-02 1992-01-29 Efamol Holdings Method of preventing reocclusion of arteries
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
PT755633E (pt) * 1995-07-28 2000-04-28 Hamm Prof Dr Michael Preparacao bifasica
DE69935995T3 (de) * 1998-10-15 2011-02-10 Dsm Ip Assets B.V. Polyungesättigen fettsäuren nährungsergänzung
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US20020068100A1 (en) * 2000-10-12 2002-06-06 Bioriginal Food & Science Corporation Combination therapy for premenstrual symptoms
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CA2953633A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8705459D0 (en) * 1987-03-09 1987-04-15 Efamol Ltd Treatment of peptic ulcers

Also Published As

Publication number Publication date
JPH0366616A (ja) 1991-03-22
ZA905437B (en) 1991-04-24
EP0409559A2 (en) 1991-01-23
DE69015910D1 (de) 1995-02-23
ATE116849T1 (de) 1995-01-15
IE64910B1 (en) 1995-09-20
EP0409559B1 (en) 1995-01-11
CA2021000A1 (en) 1991-01-22
GR3015722T3 (en) 1995-07-31
ES2066134T3 (es) 1995-03-01
DE69015910T2 (de) 1995-06-08
EP0409559A3 (en) 1991-07-03
NZ234528A (en) 1997-06-24
IE902497A1 (en) 1991-02-13
AU5911590A (en) 1991-01-24
GB8916734D0 (en) 1989-09-06
AU625705B2 (en) 1992-07-16
DK0409559T3 (da) 1995-03-27

Similar Documents

Publication Publication Date Title
HK129393A (en) Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus
AU3502289A (en) Method for administering the drug deprenyl so as to minimize the danger of side effects
ES2032382T3 (es) Metodo para preparar un medicamento para la prevencion o tratamiento de la endometriosis.
HUT60740A (en) Process for producing new thiophnecarboxylic acid esters of amino-alcohols, their quaternary derivatives and pharmaceutical compositions comprising same as active ingredient
ZA915446B (en) Growth hormone crystals and a process for production of these gh-crystals
GR3015722T3 (en) Pharmaceutical uses of fatty acids.
CA2072366A1 (en) Carboxylic acid-metal ion-acid complexes
EP0451750A3 (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
AU6213590A (en) Fatty acid therapy
AU1176688A (en) Method of treatment comprising transcutaneous administration of prostaglandin E1 derivatives
HU9201706D0 (en) Process for the production of oxazole derivatives and medical preparation containing them as active agents
GR3004487T3 (xx)
EP0294914A3 (en) Nedocromil for the treatment of dermatological disorders
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
AU1022688A (en) Antibacterial lyophilized preparation
WO1987003590A1 (en) Medicament for the treatment of diseases of the liver
EP0272057A3 (en) Pharmaceutical compositions containing pyranoquinolines
FR2648814B1 (fr) L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
AU3834189A (en) Use of essential fatty acids for the preparation of a drug for the treatment of eczema
HU9201483D0 (en) Process for the production of 1h-rh-analogues'acid additive salts, and for the production of medical preparations containing them
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
RU93016030A (ru) Лекарственное средство, стимулирующее гранулоцитарный росток кроветворения при цитостатических миелодепрессиях

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)